chr19-11128131-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000527.5(LDLR):​c.2389+46C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.244 in 1,553,346 control chromosomes in the GnomAD database, including 47,673 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 4112 hom., cov: 31)
Exomes 𝑓: 0.25 ( 43561 hom. )

Consequence

LDLR
NM_000527.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.00

Publications

16 publications found
Variant links:
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
LDLR Gene-Disease associations (from GenCC):
  • hypercholesterolemia, familial, 1
    Inheritance: AD, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-11128131-C-T is Benign according to our data. Variant chr19-11128131-C-T is described in ClinVar as Benign. ClinVar VariationId is 265907.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.371 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
NM_000527.5
MANE Select
c.2389+46C>T
intron
N/ANP_000518.1
LDLR
NM_001195798.2
c.2389+46C>T
intron
N/ANP_001182727.1
LDLR
NM_001195799.2
c.2266+46C>T
intron
N/ANP_001182728.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
ENST00000558518.6
TSL:1 MANE Select
c.2389+46C>T
intron
N/AENSP00000454071.1
LDLR
ENST00000252444.10
TSL:1
c.2647+46C>T
intron
N/AENSP00000252444.6
LDLR
ENST00000558013.5
TSL:1
c.2389+46C>T
intron
N/AENSP00000453346.1

Frequencies

GnomAD3 genomes
AF:
0.225
AC:
34227
AN:
151926
Hom.:
4107
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.189
Gnomad AMR
AF:
0.237
Gnomad ASJ
AF:
0.209
Gnomad EAS
AF:
0.386
Gnomad SAS
AF:
0.191
Gnomad FIN
AF:
0.220
Gnomad MID
AF:
0.206
Gnomad NFE
AF:
0.254
Gnomad OTH
AF:
0.226
GnomAD2 exomes
AF:
0.245
AC:
61232
AN:
250118
AF XY:
0.241
show subpopulations
Gnomad AFR exome
AF:
0.160
Gnomad AMR exome
AF:
0.256
Gnomad ASJ exome
AF:
0.217
Gnomad EAS exome
AF:
0.383
Gnomad FIN exome
AF:
0.223
Gnomad NFE exome
AF:
0.257
Gnomad OTH exome
AF:
0.253
GnomAD4 exome
AF:
0.246
AC:
344863
AN:
1401302
Hom.:
43561
Cov.:
23
AF XY:
0.244
AC XY:
170809
AN XY:
700566
show subpopulations
African (AFR)
AF:
0.149
AC:
4818
AN:
32248
American (AMR)
AF:
0.256
AC:
11412
AN:
44608
Ashkenazi Jewish (ASJ)
AF:
0.215
AC:
5538
AN:
25754
East Asian (EAS)
AF:
0.400
AC:
15755
AN:
39420
South Asian (SAS)
AF:
0.179
AC:
15221
AN:
85068
European-Finnish (FIN)
AF:
0.233
AC:
12305
AN:
52854
Middle Eastern (MID)
AF:
0.172
AC:
968
AN:
5634
European-Non Finnish (NFE)
AF:
0.250
AC:
264692
AN:
1057272
Other (OTH)
AF:
0.242
AC:
14154
AN:
58444
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
13921
27841
41762
55682
69603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8746
17492
26238
34984
43730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.225
AC:
34251
AN:
152044
Hom.:
4112
Cov.:
31
AF XY:
0.224
AC XY:
16618
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.161
AC:
6672
AN:
41502
American (AMR)
AF:
0.238
AC:
3620
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
0.209
AC:
725
AN:
3470
East Asian (EAS)
AF:
0.385
AC:
1973
AN:
5128
South Asian (SAS)
AF:
0.192
AC:
924
AN:
4822
European-Finnish (FIN)
AF:
0.220
AC:
2336
AN:
10600
Middle Eastern (MID)
AF:
0.207
AC:
61
AN:
294
European-Non Finnish (NFE)
AF:
0.254
AC:
17292
AN:
67962
Other (OTH)
AF:
0.225
AC:
476
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1342
2683
4025
5366
6708
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
370
740
1110
1480
1850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.178
Hom.:
529
Bravo
AF:
0.227
Asia WGS
AF:
0.295
AC:
1023
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hypercholesterolemia, familial, 1 Benign:4
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 01, 2016
Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:research

Mar 01, 2016
Laboratory of Genetics and Molecular Cardiology, University of São Paulo
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.052
DANN
Benign
0.54
PhyloP100
-1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2738460; hg19: chr19-11238807; COSMIC: COSV52942258; COSMIC: COSV52942258; API